Alchemab is harnessing the power of the immune system to cure disease by using nature’s most effective search engine: adaptive immunity
We are pioneering the next generation of antibody therapeutics for hard to treat diseases, with a focus on oncology and neurodegenerative disease.
We are pioneering the next generation of antibody therapeutics for hard to treat diseases, with a focus on oncology and neurodegenerative disease.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
United Kingdom
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
Solid tumour antibody
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
